Tag :

drug development Press Releases

Knowledge Management in an R&D Environment – Using an Electronic Lab Notebook as a Starting Point, New Webinar Hosted by Xtalks

Join industry experts Mats Kihlén, Product Manager at BIOVIA, and Niclas Lindberg, Sales Executive Life Sciences, TechniaTranscat, for a live webinar on Monday, Dec. 17, 2018, at 9 a.m. EST /2 p.m. GMT /3 p.m. CET (EU-Central). Sharing R&D information…

Key Considerations for the Successful Development of a Biologic: Seven Steps to Success, New Webinar Series Hosted by Xtalks

Join industry experts from Envigo for a three-part live webinar series discussing seven steps to effective biologics safety development. Part 1 of 3: Therapeutic Biology and Species Selection – is scheduled for Thursday, Nov. 29, 2018, at 11 a.m. EST…

International Association of Women Recognizes Debra Robinson as a 2018-2019 Influencer

International Association of Women Recognizes Debra Robinson as a 2018-2019 Influencer

The International Association of Women (IAW) recognizes Debra Robinson as a 2018-2019 Influencer. She is acknowledged as a leader in business. The International Association of Women (IAW) is a global in-person and online networking platform with nearly one million members,…

Drug Development – the 6 Most Critical Reasons Why Drugs Are Delayed When Planning and Conducting CTA/IND Enabling Studies, New Webinar Hosted by Xtalks

In this live webinar upcoming on Wednesday, November 21, 2018 at 11am EST (4pm GMT/UK), our featured speaker Robert Turcan, PhD, Head of Regulatory Affairs and Program Management at Envigo will explore the 6 most critical reasons why drugs are…

RxCelerate Opens UK-Based Chemistry Operations at the University of Warwick

RxCelerate Opens UK-Based Chemistry Operations at the University of Warwick

RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today it has opened UK-based chemistry operations at The University of Warwick. The new operation will be led by Dr Nigel Ramsden, who joins RxCelerate…

Transparency Life Sciences Appoints Donna Thornton Vice President, Business Development

Transparency Life Sciences (TLS), the first all-digital drug development services company, today announced that Donna Thornton has joined the company as Vice President of Business Development. She will oversee all sales efforts for the company. A 20-year veteran of the…

Is Your Biotherapeutic Immunogenic? How to Use Immunoassays to Get the Right Answer — New Webinar Hosted by Xtalks

Join Dr. Bruno Paquin, Vice President of Business Development at Immuni T and Dr. Mario Filion, Executive Vice President and CSO of Alethia Biotherapeutics on Wednesday, Oct. 3, 2018 at 1 p.m. EDT (10 a.m. PDT) for an insightful and…

Genome-Scale CRISPR Screens: Strategies to Prioritise and Validate Potential Targets, New Webinar Hosted by Xtalks

Extracting the most relevant biological data from such studies can seem daunting but, with the correct strategy, can be incredibly rewarding. Drug discovery is a challenging process that is often hindered by inefficient target identification. Functional genomics has the potential to…

Upcoming Xtalks Webinar: How the New FDA Drug-Drug Interaction Guidance Fits Within the Drug Development De-Risking Model

If all the molecules in discovery and development were added together over recent years and compared to the number of successful drug approvals each year, the ratio is (approximately) 10,000:1. [1] In other words, for every 10,000 molecules entering drug discovery,…

Biologics R&D Data Management: Why Labs Aren't Reaching Their Full Potential & Best Practices to Course Correct, New Webinar Hosted by Xtalks

Whether this is biologics experimental data recorded as part of a cell line development, upstream, downstream or analytical processes, or result and raw data generated through instrumentation, extracting, analyzing and reporting on this data in different formats, from disparate sources, can…

Different Approaches for Preparing a Marketing Application: A Review of Successful NDA/MAA Preparation Strategies, New Xtalks Webinar

Preparing your marketing application for one or more regulatory agencies is an exciting milestone in the drug development process. However, it can be a complicated and time-sensitive endeavor which is fraught with the coordination of many sequential and parallel activities…

Organ-on-a-Chip: Improving Preclinical Studies for Faster Drug Development, New Webinar Hosted by Xtalks

Organ-on-a-Chip studies are being hailed as the key to faster, more accurate drug development and precision medicine. Join industry experts from CN Bio Dr. Emma Sceats, CEO and Dr. David Hughes, CTO, for a walkthrough of the most advanced commercial…

James Bourdage to Retire as BASi VP of Bioanalytical Operations; Michael Baim Named as Successor

Bioanalytical Systems Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that James Bourdage, Ph.D., vice president of Bioanalytical Operations, will retire as of May 4, 2018. Michael Baim, Ph.D., will assume the role of vice president of Bioanalytical Operations effective May 7, 2018.…

Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification, New Webinar Hosted by Xtalks

In this live presentation, featured speakers from KCAS Gene Ray, Ph.D., Senior Scientific Advisor and Lawrence Goodwin, Executive Director of Bioanalytical R&D and LC-MS/MS Services will highlight bioanalytical challenges in drug discovery and some potential solutions. Examples to be presented…

Scientists Fix Genetic Risk Factor for Alzheimer's Disease in Human Brain Cells

Scientists Fix Genetic Risk Factor for Alzheimer's Disease in Human Brain Cells

Using human brain cells, scientists at the Gladstone Institutes discovered the cause of — and a potential solution for — the primary genetic risk factor for Alzheimer’s disease, a gene called apoE4. Having one copy of the apoE4 gene more…

Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced today that it will report financial results for the first quarter of fiscal 2018 ended December 31, 2017, prior to the market opening on Tuesday, February 13, 2018. If there…

BASi Continues Profitability Improvement to Close Out Fiscal 2017

BASi Continues Profitability Improvement to Close Out Fiscal 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) (" BASi" or the "Company") today announced financial results for the three and twelve months ended September 30, 2017. Fourth Quarter Results For the three months ended September 30, 2017, revenue amounted to $5,873,000, a 14%…

Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017

Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the fourth quarter and twelve months ended September 30, 2017, prior to the market opening on Tuesday, December 19, 2017. If there are…

BASi Announces Enhanced Bioequivalence Capabilities

BASi Announces Enhanced Bioequivalence Capabilities

Bioanalytical Systems Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced a multi-tiered strategy aimed at enhancing the company’s in vitro and in vivo bioequivalence capabilities. Over the next several months, BASi will hire additional Principal Investigators and Research Analysts to support…

New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom

New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom

Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence (www.beacon-intelligence.com), to provide clarity to scientists and strategists in the booming immuno-oncology combination field of study. IO Combination Trials Intelligence is part of Hanson Wade’s Beacon…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login